Gallion HH - Search Results

1

Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21.

Steichen-Gersdorf E, Gallion HH, Ford D, Girodet C, Easton DF, DiCioccio RA, Evans G, Ponder MA, Pye C, Mazoyer S, et al. Steichen-Gersdorf E, et al. Among authors: gallion hh. Am J Hum Genet. 1994 Nov;55(5):870-5. Am J Hum Genet. 1994. PMID: 7977348 Free PMC article.

2

Localisation of the breast-ovarian cancer susceptibility gene (BRCA1) on 17q12-21 to an interval of < or = 1 cM.

Smith SA, DiCioccio RA, Struewing JP, Easton DF, Gallion HH, Albertsen H, Mazoyer S, Johansson B, Steichen-Gersdorf E, Stratton M, et al. Smith SA, et al. Among authors: gallion hh. Genes Chromosomes Cancer. 1994 May;10(1):71-6. doi: 10.1002/gcc.2870100112. Genes Chromosomes Cancer. 1994. PMID: 7519878

3

Hypermethylation at a chromosome 17 "hot spot" is a common event in ovarian cancer.

Pieretti M, Powell DE, Gallion HH, Conway PS, Case EA, Turker MS. Pieretti M, et al. Among authors: gallion hh. Hum Pathol. 1995 Apr;26(4):398-401. doi: 10.1016/0046-8177(95)90140-x. Hum Pathol. 1995. PMID: 7705818

4

Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors.

Pieretti M, Powell DE, Gallion HH, Case EA, Conway PS, Turker MS. Pieretti M, et al. Among authors: gallion hh. Hum Pathol. 1995 Apr;26(4):393-7. doi: 10.1016/0046-8177(95)90139-6. Hum Pathol. 1995. PMID: 7705817

5

High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.

Wilcox CB, Baysal BE, Gallion HH, Strange MA, DeLoia JA. Wilcox CB, et al. Among authors: gallion hh. Cancer Genet Cytogenet. 2005 Jun;159(2):114-22. doi: 10.1016/j.cancergencyto.2004.12.017. Cancer Genet Cytogenet. 2005. PMID: 15899382

6

Evidence for a unifocal origin in familial ovarian cancer.

Gallion HH, Guarino A, DePriest PD, van Nagell JR Jr, Vaccarello L, Berek JS, Pieretti M. Gallion HH, et al. Am J Obstet Gynecol. 1996 Apr;174(4):1102-6; discussion 1106-8. doi: 10.1016/s0002-9378(96)70651-8. Am J Obstet Gynecol. 1996. PMID: 8623836

7

The molecular basis of ovarian cancer.

Gallion HH, Pieretti M, DePriest PD, van Nagell JR Jr. Gallion HH, et al. Cancer. 1995 Nov 15;76(10 Suppl):1992-7. doi: 10.1002/1097-0142(19951115)76:10+<1992::aid-cncr2820761315>3.0.co;2-u. Cancer. 1995. PMID: 8634990 Review.

8

Genetic alterations distinguish different types of ovarian tumors.

Pieretti M, Cavalieri C, Conway PS, Gallion HH, Powell DE, Turker MS. Pieretti M, et al. Among authors: gallion hh. Int J Cancer. 1995 Dec 20;64(6):434-40. doi: 10.1002/ijc.2910640614. Int J Cancer. 1995. PMID: 8550247

9

BRCA1-related and sporadic ovarian cancer in the same family: implications for genetic testing.

Richards WE, Gallion HH, Schmittschmitt JP, Holladay DV, Smith SA. Richards WE, et al. Among authors: gallion hh. Gynecol Oncol. 1999 Dec;75(3):468-72. doi: 10.1006/gyno.1999.5645. Gynecol Oncol. 1999. PMID: 10600309

10

BRCA1 germline mutations and polymorphisms in a clinic-based series of ovarian cancer cases: a Gynecologic Oncology Group study.

Smith SA, Richards WE, Caito K, Hanjani P, Markman M, DeGeest K, Gallion HH. Smith SA, et al. Among authors: gallion hh. Gynecol Oncol. 2001 Dec;83(3):586-92. doi: 10.1006/gyno.2001.6430. Gynecol Oncol. 2001. PMID: 11733976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page